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AbstrAct
background The use of health data for public health, surveillance, quality 
improvement and research is crucial to improve health systems and health care. 
However,  bodies responsible for privacy and ethics often limit access to routinely 
collected health data. Ethical approvals, issues around protecting privacy and data 
access are often dealt with by different layers of regulations, making approval pro-
cesses appear disjointed. 
Objective To create a comprehensive framework for defining the ethical and 
 privacy status of a project and for providing guidance on data access. 
Method The framework comprises principles and related questions. The core 
of the framework will be built using standard terminology definitions such as eth-
ics-related controlled vocabularies and regional directives. It is built in this way to 
reduce ambiguity between different definitions. The framework is extensible: prin-
ciples can be retired or added to, as can their related questions. Responses to 
these questions should allow data processors to define ethical issues, privacy risk 
and other unintended consequences. 
results The framework contains three steps: (1) identifying possible ethical and 
privacy principles relevant to the project; (2) providing ethics and privacy guidance 
questions that inform the type of approval needed; and (3) assessing case-specific 
ethics and privacy issues. The outputs from this process should inform whether 
the balance between public interests and privacy breach and any ethical consider-
ations are tipped in favour of societal benefits. If they are then this should be the 
basis on which data access is permitted. Tightly linking ethical principles to gover-
nance and data access may help maintain public trust.
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INtrODUctION
Health research projects conducted in an international  setting 
are increasingly attempting to bring together large data sets 
utilising patient’s computerised medical record data.1 Advances 
in secure computational methods make projects of this nature 
feasible and able to meet strict information  governance stan-
dards that reduce the chances of any breach in privacy. 
Privacy and ethical issues in real-life projects are complex 
and often project specific. Variations in published guidelines 
are influenced by the type of study participants, funding bod-
ies, regional legislation, and so on.2 Despite these differences, 
privacy and ethics are fundamental principles in biomedical 
science. The privacy and ethical framework described in this 
paper provides a generic evidence-based approach, with a 
focus on linking principles to practical questions that inform 
the approvals required to enable health data access. It rec-
ognises that research must be in the public interest and have 
citizens’ trust.3,4 
NEED FOr A PrAGMAtIc APPrOAcH FOr 
DEALING WItH PrIVAcY AND EtHIcAL 
IssUEs
Many projects deal with ethical, privacy and data access issues 
within the same work package or committee. However, while 
they might be grouped together at the  project-level, ethical 
approvals (if any) required for surveillance, quality improvement 
(QI) and research projects are subject to layers of regulation 
different from those that ensure privacy standards. Approvals 
are generally made by separate bodies that deal with specific 
areas. In general research ethics approval, or exemption from 
it, is dealt with separately from data protection and information 
governance. Moreover, approvals for international studies are 
obtained from separate bodies in different countries. This paper 
proposes a pragmatic methodology for researchers who want 
to use health care data for research, surveillance and service 
evaluation projects spanning from a conceptual framework to 
actionable assessment techniques. 
bUILDING A PrIVAcY AND EtHIcAL 
FrAMEWOrK
The privacy and ethical framework consists of a set of privacy 
and ethical assessment principles derived by a review of the 
relevant ethics and privacy literature (Table 1). The associ-
ated questions were developed by translating principles to fit 
the context of the potential use cases that the  principles will 
be applied to. We considered examples in the existing litera-
ture that highlighted implications of applying (or not applying) 
privacy and ethical principles within specific health research 
settings or scenarios. 
The framework adopts controlled vocabularies and standard 
definitions to ensure consistent understanding of the privacy 
and ethical principles. The set of principles and questions are 
extensible and can evolve in a manner that can absorb new 
research in the area and to adapt to changing legislations. The 
principles and questions are referenced to their original source. 
table 1 Key information sources
First Author Year Brief title Contribution Step of framework 
1 Beauchamp 1994 Methods and principles in biomedical ethics Text book with an emphasis on the four core 
ethical principles (respect for autonomy, non-
maleficence, beneficence and justice)
Ethical principles
2 Thompson 2006 Pandemic influenza preparedness: an 
ethical framework to guide decision making
Proposed a framework including 10 ethical values 
in the context of influenza epidemics.
Ethical principles
3 Tangwa 2009 Ethical principles in health research and 
review process
Reports ethical principles and related case 
studies 
Ethical principles
4 Malin 2011 Identifiability in biobanks: models, 
measures and mitigation strategies
Discusses several key privacy characteristics 
specifically focusing on identifiability. 
Privacy principles
5 Faden 2013 An ethical framework for a learning health 
care system
Describes an ethical framework with 7 ethical 
obligations in learning health care systems.
Ethical principles
6 Di Iorio 2013 Cross-border flow of health information: is 
‘privacy by design’ enough?
Proposes a privacy assessment framework with 
11 privacy factors. 
Privacy principles
7 Babu 2014 An appraisal of the tuberculosis programme 
in India using an ethical framework
Summarises a set of 5 ethical issues associated 
to public health initiatives. 
Ethical principles
8 Willison 2014 What makes public health studies ethical? Provides ethical guiding questions for public 
health studies
Ethical guidance 
questions
9 O.E.C.D 2015 Health data governance: privacy, 
monitoring and research
Provides key health data governance 
mechanisms to maximise privacy risks and 
societal benefits
Data governance and 
privacy guidelines
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cONtrOLLED VOcAbULArIEs FOr 
rEPrEsENtING PrIVAcY AND EtHIcs
Controlled vocabularies are important to ensure consis-
tency of the concepts used across studies and in differ-
ent countries.5 This approach is needed because the 
terminologies used for describing privacy, ethics and data 
access concepts are diverse. For example, the definitions 
of terms such as ‘data owner’, ‘data custodian’ and ‘data 
processor’ have overlapping meanings. Legal definitions, 
in the field of data protection, are often used very differently 
from how the same terms are used in research projects. 
We have built on a prior initiative for developing  controlled 
vocabularies and ontologies in this domain.6 We have 
extended this work by enriching the controlled vocabularies 
with additional findings from our  literature survey and by 
adopting standard definitions accepted within the domain 
(e.g. European Union Data Protection Directive,7 or other 
regionally appropriate definitions such as the Australian 
Privacy Principles8). 
step 1: Exploring ethical and privacy principles
The first step is to consider key (1) ethical and (2) pri-
vacy principles relevant to the research being conducted. 
Areas are included, or not, depending on the nature of 
the study.1,9–16
step 2: Ethical and privacy questions to inform 
the approvals needed 
The second stage involves asking and answering the 
ethical and privacy guidance questions for the principles 
that apply to that study. The guidance questions will be 
grounded on the identified ethical principles. They will 
support privacy and ethical evaluation of research studies 
and issues that arise during the lifetime of the projects. 
Researchers should include privacy and ethical consid-
erations relevant to their study design and through this 
process identify what approvals are needed.17 Data cus-
todians can also use these questions to assess requests 
to share data. 
step 3: should access to data be granted?
The responses to questions in Step 2 should inform 
whether there is an ethical basis for data access. Key 
areas to consider are: (1) mitigation strategies to be 
implemented to conform to privacy and ethical principles; 
(2) data flow modifications, that is any change in data 
processing to enhance privacy (e.g. use of aggregated 
data rather than with identifiable personal information); 
(3) what local approvals need to be put in place, which 
may be nationally stipulated and (4) protocols for data 
access; the use of pooled data may be authorised; alter-
natively, distributed analysis or a hybrid. 
UsE cAsEs
The framework can be represented as a number of use cases 
involving multiple stakeholders; they will vary according to the 
type of study. The overall use case diagram for the framework 
is illustrated in Figure 1. ‘Use cases’ are generally used to 
model systems and their interactions in software  engineering. 
They describe a story of how a system and its actors (those 
who engage in various interactions with the system) col-
laborate to achieve a specific goal. These diagrams are 
frequently used while gathering technical requirements asso-
ciated with health information systems.18,19 We have followed 
Unified Modelling Language use case notation as given in the 
Rational Unified Process to create these diagrams.20
1. Researchers and research ethics committees: The 
same principles and questions should apply to all 
involved in research. Privacy and ethics are included 
in the design of a study, and generally studies go on 
to receive ethical approval as the potential issues are 
considered from the initial stages. The actors in this 
use case will typically involve primary investigators 
who design the study, the ethics committee members 
who approve studies and data custodians who 
provide approval for data access. The ethics of 
research studies will have a higher degree of scrutiny 
as interventions might include new treatments. 
2. QI: A narrower range of privacy and ethical 
considerations generally apply to QI initiatives. 
Protection of public from harm is generally not an issue 
Ethical principles Privacy principles
1) Autonomy 
2) Respect rights and dignity of 
patients
3) Respect clinical judgment of 
clinician
4) Duty to Provide Care 
5) Protection of the public from 
harm
6) Beneficence
7) Justice
8)  Non-maleficence (an obligation 
not to inflict harm intentionally)
9) Reciprocity 
10) Solidarity 
11) Stewardship 
12) Trust 
13) Lawfulness
14)  Transparent project approval 
process
1) Accountability of personal 
information
2) Collection of personal 
information 
3) Consent
4) Use of personal information 
5) Disclosure and disposition of 
personal information
6) Accuracy of personal 
information 
7) Safeguarding personal 
information
8) Openness/transparency
9) Individual access to personal 
information
10)  Challenging compliance 
to ensure accountability is 
achievable
11)  Anonymisation process for 
secondary uses of health data
12) Lawfulness
13) De-identification process
14) Data linkage
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concerns might arise when stratifying populations into 
narrow age-bands or localities and in the reporting 
of rare events. During epidemic outbreaks, personal 
data and samples may need to be collected for 
public health purposes. Whilst the privacy and ethical 
considerations applied in this use case are limited, 
patients should still be given the right to opt out of 
their data being used for surveillance. 
The use cases also involve representatives from the pub-
lic including patients, carers (generally parents in the case 
of children) and non-patient citizens. Present-day research 
studies should have a high level of patient and public 
engagement throughout the research process. Patient group 
representatives should get involved as early as the design 
stage of the study to ensure that studies are likely to be ben-
eficial to patients and to help maintain wider public trust. We 
have drawn secondary-level use cases suggesting how the 
privacy and ethical framework will be utilised (Figures 2–4). 
as most parts of those studies usually have a high 
degree of patient safety in built. Treatment used in QI 
studies are already approved and whether to treat is 
decided by both the clinician and the patient according 
to clinical standards and patient’s preference. As data 
are generally handled at a local level, data sharing is 
less complicated in this use case. 
3. Surveillance: Generally, using data for disease 
surveillance is part of a health system’s public health 
functions and therefore fewer ethical principles apply. 
However, a duty of privacy remains where data are 
further used to inform QI or research; in which case 
different principles pertain. Data are mostly reported 
as aggregated summaries and the unit used for 
reporting is generally regional or city level though 
sentinel surveillance networks report at the national 
level. The unit of reporting largely ensures that 
privacy of individuals is maintained despite reports 
are published at regular intervals. However, privacy 
Privacy and ethics framework
Compile Generic Privacy
& Ethics Knowledge-base
Privacy & Ethics
Assessement Creation
Privacy/ethics experts
Ethics committees
Data custodians
Researchers
Patients Citizens Carers
P & E framework
developers
Quality improvement
Research study
evaluation/approval Surveillance
Figure 1 Overall use case diagram for the privacy and ethical framework. the box indicates the system of interest and the 
oval within corresponds to the processes within the system that are inter-related. the actors who interact with the system 
(and its processes) are drawn around the box
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Figure 2 the use case utilising the privacy and ethics framework in the context of research studies. research requires 
the greatest level of scrutiny and involvement of actors – eight different actors are identified as important in this process. 
citizens are important as research in the public interest must also be acceptable to citizens. Patients include consenting 
research participants and carers include parents and those with power of attorney
Figure 3 the use case for utilising the privacy and ethics framework for QI studies. Generally, ethical approval is not 
required here in contrast to the research use case. Public interest is also important in this use case. QI studies requires  
a protocol just as research studies
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sUMMArY
This paper describes an extensible framework that can be 
used to explore the ethical and privacy principles related to 
research, QI and surveillance. The framework links to key 
questions that help ensure that important issues are identi-
fied. Further research is needed to test the reliability of this 
approach and the completeness and validity of the principles 
included in it. This is planned as an activity of the International 
Medical Informatics Association and European Federation for 
Medical Informatics Primary Health Care Working Groups. 
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APPENDIx A – EtHIcAL GUIDANcE QUEstIONs
Adapted from Willison et al. (2014)
1. What are the burdens and potential harms associated with the proposed initiative? Who bears them?
2. Are burdens and potential harms justified in light of the potential benefits to participants and/or to society?
3. Is the selection of participants fair and appropriate?
4. Is individual informed consent warranted? Is it feasible? Is it appropriate? Is it sufficient?
5. Is community engagement warranted? Is it feasible? What level of engagement is appropriate?
6. What are the social justice implications of this initiative?
7. What are the potential longer term consequences?
APPENDIx b – PrIVAcY AND DAtA AccEss GUIDANcE QUEstIONs
1.     Who is accountable for the data and where will it be stored?
2.     Who will have access to the data?
3.     Is there an audit trail to indicate that the data was obtained lawfully?
4.     Has sufficient level of anonymisation achieved?
5.     Are there any restrictions for secondary processing the data?
6.     Can the accuracy of the data be verified?
7.     Are the data processing/transformation processes documented and approved?
8.     Is there a method where individuals can opt out of being included from the data?
